News | July 01, 2022
H Clinical adds commercial home health capabilities for pharma industry
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
In the Phase 3 LIBRETTO-431 study, Retevmo more than doubled progression-free survival (PFS) compared to chemotherapy plus pembrolizumab in patients with advanced or metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC)
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)